Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
about
Biomarkers in Multiple Sclerosis: An Up-to-Date OverviewComparison of optical coherence tomography and scanning laser polarimetry measurements in patients with multiple sclerosis.Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.Evaluation of Visual-Evoked Cerebral Metabolic Rate of Oxygen as a Diagnostic Marker in Multiple SclerosisRetinal architecture and mfERG: Optic nerve head component response characteristics in MSMultifocal and pattern-reversal visual evoked potentials vs. automated perimetry frequency-doubling technology matrix in optic neuritis.Neuroprotection in multiple sclerosis: a therapeutic approach.Optical coherence tomography in multiple sclerosis and neuromyelitis optica: an updateSteady-state multifocal visual evoked potential (ssmfVEP) using dartboard stimulation as a possible tool for objective visual field assessment.Relationship between Structural and Functional Assessment of the Visual System in Mildly Disabled Relapsing-Remitting Multiple Sclerosis PatientsQuantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis.Comparison of multifocal visual evoked potential, static automated perimetry, and optical coherence tomography findings for assessing visual pathways in patients with pituitary adenomas.Electroretinography and Visual Evoked Potentials in Childhood Brain Tumor Survivors.Visual field impairment captures disease burden in multiple sclerosis.
P2860
Q27496017-548F74F6-6C4B-4696-99DE-FB1766739452Q33585136-361A4A91-6784-4F58-B0F9-A8D404EBBF26Q33771464-F02A228D-D664-47A4-8ED7-59ACA1208DAEQ33831782-10598E28-F97C-4B55-90DC-E12889005F05Q33927190-76A0DCFC-395C-49EE-B636-794905672116Q36801020-5EBB7759-85EA-4A72-8635-1123B828C190Q38129748-0482208E-3150-4224-8B81-271C6B8F3902Q38743810-62F92A10-AC96-4534-95C7-8EE9D571FFC1Q38944428-954CCA3A-89B8-4718-960D-5DA82DD5FD06Q42363523-3915177D-C489-4437-B55C-C155BF38E446Q43121362-B798AED7-7E50-4A26-807C-55D00E03B11FQ44278708-3E28919E-FDC6-4C01-BE8C-635B764D7012Q46079192-35A677AB-7EFA-4423-9C05-536F883405C5Q48858505-B91CF968-9AF7-44EE-BC93-82B2934B0679Q48919888-878E3E1C-B8E1-48E6-8855-2F610A6C6123
P2860
Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Comparison of multifocal visua ...... n multiple sclerosis patients.
@ast
Comparison of multifocal visua ...... n multiple sclerosis patients.
@en
Comparison of multifocal visua ...... n multiple sclerosis patients.
@nl
type
label
Comparison of multifocal visua ...... n multiple sclerosis patients.
@ast
Comparison of multifocal visua ...... n multiple sclerosis patients.
@en
Comparison of multifocal visua ...... n multiple sclerosis patients.
@nl
prefLabel
Comparison of multifocal visua ...... n multiple sclerosis patients.
@ast
Comparison of multifocal visua ...... n multiple sclerosis patients.
@en
Comparison of multifocal visua ...... n multiple sclerosis patients.
@nl
P2093
P2860
P356
P1476
Comparison of multifocal visua ...... n multiple sclerosis patients.
@en
P2093
Jade S Schiffman
Laura J Frishman
Michal Laron
Rosa A Tang
P2860
P304
P356
10.1177/1352458509359782
P577
2010-03-05T00:00:00Z